Introduction Patients with chronic bronchitis suffer high morbidity and rapid functional decline; thus, novel treatments are ...
Temperatures in the Bitterroot Valley have reached the warmest of the summer, ranging between 85 and 105 degrees.
Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy July 7, 2026 4:30 PM EDTCompany ParticipantsSean Grant ...
If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to treat HAE attacksNDA includes positive data from ...
Reflective Soul Therapy & Wellness Launches Revamped Integrated Care Services in Kelowna Kelowna, Canada - July 5, 2026 ...
The accelerated approval for Jazz Pharmaceuticals’ small cell lung cancer (SCLC) drug Zepzelca may once again be in jeopardy. Friday, Jazz said the phase 3 Lagoon trial has failed on its primary ...
Association between chemotherapy-induced neuropathy and gabapentin exposure among adults receiving chemotherapy: A National Inpatient Sample study (2017-2021). This is an ASCO Meeting Abstract from ...
More than three years after Gilead Sciences’ hepatitis D drug bulevirtide was rebuffed by the FDA due to manufacturing and delivery concerns, the treatment has since redeemed itself by scoring a green ...
Aleksandar Alchev is a Director of Business Development at Minnesota Urology, overseeing the practice’s In-Office Dispensary, Prostate Cancer Navigation, Cancer Center Operations, and Men’s Health ...
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV) – Chronic HDV is considered the most severe ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex ® (bulevirtide-gmod) 8.5 mg for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results